Literature DB >> 10772929

LDL receptor-related protein as a component of the midkine receptor.

H Muramatsu1, K Zou, N Sakaguchi, S Ikematsu, S Sakuma, T Muramatsu.   

Abstract

Midkine (MK) is a heparin-binding growth factor with migration-promoting and survival-promoting activities. To identify signaling receptor(s) of MK, membrane glycoproteins with MK-binding activity were isolated from day 13 mouse embryos by lectin- and MK-affinity chromatography. SDS-PAGE followed by protein sequence analysis revealed the presence of LDL receptor-related protein (LRP) and NCAM in the fraction. The dissociation constant of binding between LRP and MK was 3.5 nM. Receptor-associated protein (RAP), which interfered with the binding, inhibited MK-dependent survival of embryonic neurons. Brushin/megalin, which is also a high molecular weight protein belonging to the LDL receptor family, bound to MK less strongly than LRP. These findings suggest that LRP is a component of the receptor complex for MK. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10772929     DOI: 10.1006/bbrc.2000.2549

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  45 in total

1.  The cytokine midkine and its receptor RPTPζ regulate B cell survival in a pathway induced by CD74.

Authors:  Sivan Cohen; Or-yam Shoshana; Einat Zelman-Toister; Nitsan Maharshak; Inbal Binsky-Ehrenreich; Maya Gordin; Inbal Hazan-Halevy; Yair Herishanu; Lev Shvidel; Michal Haran; Lin Leng; Richard Bucala; Sheila Harroch; Idit Shachar
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

2.  Nuclear targeting by the growth factor midkine.

Authors:  Yoshihisa Shibata; Takashi Muramatsu; Makoto Hirai; Tatsuya Inui; Terutoshi Kimura; Hidehiko Saito; Lynn M McCormick; Guojun Bu; Kenji Kadomatsu
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 3.  Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit.

Authors:  Hitoshi Ishimoto; Robert B Jaffe
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

Review 4.  Structure and function of midkine as the basis of its pharmacological effects.

Authors:  T Muramatsu
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 5.  Pancreatic cancer.

Authors:  C Güngör; B T Hofmann; G Wolters-Eisfeld; M Bockhorn
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

6.  Midkine promotes selective expansion of the nephrogenic mesenchyme during kidney organogenesis.

Authors:  Libo Qiu; Deborah P Hyink; William H Gans; Kurt Amsler; Patricia D Wilson; Christopher R Burrow
Journal:  Organogenesis       Date:  2004-07       Impact factor: 2.500

Review 7.  The midkine family of growth factors: diverse roles in nervous system formation and maintenance.

Authors:  C Winkler; S Yao
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 8.  Therapeutic potential of midkine in cardiovascular disease.

Authors:  Kenji Kadomatsu; Péter Bencsik; Anikó Görbe; Csaba Csonka; Kazuma Sakamoto; Satoshi Kishida; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

9.  Low and high affinity receptors mediate cellular uptake of heparanase.

Authors:  Olga Ben-Zaken; Itay Shafat; Svetlana Gingis-Velitski; Haim Bangio; Idil Kasuto Kelson; Tal Alergand; Yehudit Amor; Ruth Ben-Yakar Maya; Israel Vlodavsky; Neta Ilan
Journal:  Int J Biochem Cell Biol       Date:  2007-09-29       Impact factor: 5.085

10.  Midkine inhibitors: application of a simple assay procedure to screening of inhibitory compounds.

Authors:  Takashi Matsui; Keiko Ichihara-Tanaka; Chen Lan; Hisako Muramatsu; Toshiharu Kondou; Chizuru Hirose; Sadatoshi Sakuma; Takashi Muramatsu
Journal:  Int Arch Med       Date:  2010-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.